Becton, Dickinson and Company
BDXA
NYSE·Healthcare·Medical - Instruments & Supplies·Mkt cap $55.9B
$59.24
▼ -2.24%
P/E
17.84
Mkt Cap
$55.9B
52-Wk Range
$49.07–$64.12
52-Week Range
$49.07 - $64.12
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Price chart
Up 0.0% over the trailing year
Total returns
Price performance
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
The thesis at a glance
Bull and bear case · plain-English context across the five lenses we evaluate.
Bull Case
No bull reasons captured for this rating yet.
Bear Case
1 risk
- Low volatility (beta 0.0).
Growth
No forward estimates available
Value
Valuation data unavailable
Momentum
Stable
+0.0% over 3m
Quality
Strong
Solid business
Dividend
Solid
2.03% yield
Smart-money signal
Who's buying BDXA right now
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
Recent earnings results
AI-summarized recap of last quarter, plus the surprise on every print.
Most recent quarter reported revenue of $5.0B (-10% YoY). Reported EPS of $1.37.
Reported EPS · last 4Q
Q3 26
$1.37
Q2 26
-$1.11
Q1 26
$1.34
Q4 25
$1.72
Revenue trend · last 8Q
—
—
—
—
+8%
+2%
-11%
-10%
Q4 24
Q1 25
Q2 25
Q3 25
Q4 25
Q1 26
Q2 26
Q3 26
$5.4B
$5.2B
$5.3B
$5.5B
$5.9B
$5.3B
$4.7B
$5.0B
Margins · last 8Q
Profit
7.6%
Wall Street consensus
Analyst coverage
Live ratings and price targets aggregated across covering analysts.
vs Industry
How BDXA stacks vs Medical - Instruments & Supplies
Stock metrics vs industry averages. Green = better than industry.
Industry comparison data unavailable for this stock.